Migliorini Filippo, Eschweiler Jörg, Maffulli Nicola, Schenker Hanno, Baroncini Alice, Tingart Markus, Rath Björn
Department of Orthopedics and Trauma Surgery, University Clinic Aachen, RWTH Aachen University Clinic, 52064 Aachen, Germany.
Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, 84081 Baronissi, Italy.
Life (Basel). 2021 Feb 25;11(3):183. doi: 10.3390/life11030183.
The potential of autologous matrix-induced chondrogenesis (AMIC) to restore unipolar focal chondral defects of the knee is promising. However, the outcome compared to microfracturing (MFx) for certain defect sizes (2-3 cm) is still uncertain. Therefore, the present study compared primary isolated AMIC versus MFx in a cohort of patients with borderline sized focal unipolar chondral defects of the knee at midterm follow-up. Patients with chondral defects of the knee who underwent AMIC or MFx were compared. An arthroscopic approach was used for MFx, and a minimally invasive parapatellar arthrotomy for AMIC. For those patients who underwent AMIC, a collagen membrane was used with fibrin glue. The patients answered independently: Visual Analogic Scale (VAS), Tegner Activity Scale, International Knee Documentation Committee (IKDC), and the Lysholm scores. A total of 83 patients with a mean age of 30.2 and body mass index (BMI) of 26.9 kg/m were recruited. Of them, 33.7% (28 of 83) were women, and 55.4% (46 of 83 patients) had defects in the right knee. The mean length of symptoms before surgery was 43.3 months. The mean size of the defect was 2.7 cm. The mean length of follow-up was 42.1 months. No difference was found in terms of symptoms and follow-up length, mean age and BMI, mean size of defect, sex, and side. The AMIC cohort reported greater IKCD ( > 0.0001), Lysholm ( = 0.002), VAS ( = 0.01), Tegner ( = 0.004) scores. The AMIC cohort reported lower rate of failure ( = 0.005) and revision surgery ( = 0.02). No difference was found in the rate of arthroplasty ( = 0.2). No delamination or hypertrophy were detected. AMIC demonstrated superiority over MFx for focal unipolar chondral defects of the knee. At approximately 40 months follow-up, the IKDC, Lysholm, and VAS scores were greater in the AMIC group. Patients treated with AMIC also demonstrated a higher level of sport activity, and lower rates of failure and revision surgeries.
自体基质诱导软骨形成术(AMIC)修复膝关节单极局灶性软骨缺损的潜力很有前景。然而,对于某些特定缺损大小(2 - 3厘米),与微骨折术(MFx)相比,其结果仍不确定。因此,本研究在中期随访时,比较了原发性孤立性AMIC与MFx在一组膝关节边缘性大小局灶性单极软骨缺损患者中的效果。对接受AMIC或MFx治疗的膝关节软骨缺损患者进行了比较。微骨折术采用关节镜入路,AMIC采用微创髌旁关节切开术。对于接受AMIC治疗的患者,使用胶原膜并结合纤维蛋白胶。患者独立回答视觉模拟评分量表(VAS)、泰格纳活动量表、国际膝关节文献委员会(IKDC)和利绍姆评分。共招募了83例患者,平均年龄30.2岁,体重指数(BMI)为26.9kg/m 。其中,33.7%(83例中的28例)为女性,55.4%(83例患者中的46例)右膝有缺损。术前症状的平均持续时间为43.3个月。缺损的平均大小为2.7厘米。平均随访时间为42.1个月。在症状和随访时长、平均年龄和BMI、缺损平均大小、性别及患侧方面未发现差异。AMIC组的IKCD评分(>0.0001)、利绍姆评分(=0.002)、VAS评分(=0.01)、泰格纳评分(=0.004)更高。AMIC组报告的失败率(=0.005)和翻修手术率(=0.02)更低。在关节置换率方面未发现差异(=0.2)。未检测到分层或肥大现象。对于膝关节单极局灶性软骨缺损,AMIC显示出优于MFx的效果。在大约40个月的随访中,AMIC组的IKDC、利绍姆和VAS评分更高。接受AMIC治疗的患者也表现出更高水平的体育活动,以及更低的失败率和翻修手术率。